These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 17118607)

  • 21. Kinetics and mechanism of degradation of cefotaxime sodium in aqueous solution.
    Berge SM; Henderson NL; Frank MJ
    J Pharm Sci; 1983 Jan; 72(1):59-63. PubMed ID: 6298400
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Study on chemical changes of salvianolic acid B and lithospermic acid aqueous under conditions of high temperature and high pressure].
    Wang Y; Zhu J; Fu S; Zhu L; Zhang Y
    Zhongguo Zhong Yao Za Zhi; 2011 Feb; 36(4):434-8. PubMed ID: 21598535
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Degradation kinetics study of cabozantinib by a novel stability-indicating LC method and identification of its major degradation products by LC/TOF-MS and LC-MS/MS.
    Wu C; Xu X; Feng C; Shi Y; Liu W; Zhu X; Zhang J
    J Pharm Biomed Anal; 2014 Sep; 98():356-63. PubMed ID: 24992215
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Degradation study of the investigational anticancer drug clanfenur.
    Sluiter C; Kettenes-van den Bosch JJ; Hop E; van der Houwen OA; Underberg WJ; Bult A
    Int J Pharm; 1999 Aug; 185(2):227-35. PubMed ID: 10460918
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A systematic study on the chemical stability of ifosfamide.
    Kaijser GP; Beijnen JH; Bult A; Hogeboom MH; Underberg WJ
    J Pharm Biomed Anal; 1991; 9(10-12):1061-7. PubMed ID: 1822174
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Degradation kinetics in aqueous solution of cefotaxime sodium, a third-generation cephalosporin.
    Fabre H; Eddine NH; Berge G
    J Pharm Sci; 1984 May; 73(5):611-8. PubMed ID: 6330342
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Degradation kinetics of a new cephalosporin derivative in aqueous solution.
    Rattie ES; Zimmerman JJ; Ravin LJ
    J Pharm Sci; 1979 Nov; 68(11):1369-74. PubMed ID: 41933
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Degradation kinetics of fluorouracil-acetic-acid-dextran conjugate in aqueous solution.
    Hao AJ; Deng YJ; Li TF; Suo XB; Cao YH; Hao YL; Zhang Y
    Drug Dev Ind Pharm; 2006 Jul; 32(6):757-63. PubMed ID: 16885130
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Degradation of dacarbazine in aqueous solution.
    Shetty BV; Schowen RL; Slavik M; Riley CM
    J Pharm Biomed Anal; 1992 Sep; 10(9):675-83. PubMed ID: 1286132
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stability studies of gabapentin in aqueous solutions.
    Zour E; Lodhi SA; Nesbitt RU; Silbering SB; Chaturvedi PR
    Pharm Res; 1992 May; 9(5):595-600. PubMed ID: 1608888
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An ammonium sulfate/ethanol aqueous two-phase system combined with ultrasonication for the separation and purification of lithospermic acid B from Salvia miltiorrhiza Bunge.
    Guo YX; Han J; Zhang DY; Wang LH; Zhou LL
    Ultrason Sonochem; 2012 Jul; 19(4):719-24. PubMed ID: 22265019
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stability of ertapenem in aqueous solutions.
    Zajac M; Cielecka-Piontek J; Jelińska A
    J Pharm Biomed Anal; 2007 Jan; 43(2):445-9. PubMed ID: 16914282
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epimer interconversion, isomerization, and hydrolysis of tetrahydrouridine: implications for cytidine deaminase inhibition.
    Xiang TX; Niemi R; Bummer P; Anderson BD
    J Pharm Sci; 2003 Oct; 92(10):2027-39. PubMed ID: 14502542
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Kinetics and mechanism of 2,3,5,4'-tetrahydroxystilbene-2-O-β-d-glycoside (THSG) degradation in aqueous solutions.
    Ren XL; Wang GF; Wang M; Ou-Yang HZ; Qi AD
    J Pharm Biomed Anal; 2011 Apr; 55(1):211-5. PubMed ID: 21282026
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nefopam hydrochloride degradation kinetics in solution.
    Tu YH; Wang DP; Allen LV
    J Pharm Sci; 1990 Jan; 79(1):48-52. PubMed ID: 2313576
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Degradation kinetics of mometasone furoate in aqueous systems.
    Teng XW; Cutler DC; Davies NM
    Int J Pharm; 2003 Jun; 259(1-2):129-41. PubMed ID: 12787642
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stability of the new antileukemic 4-pyranone derivative, BTMP, using HPLC and LC-MS analyses.
    Novotny L; Abdel-Hamid M; Hamza H; Rauko P; Uher M; Brtko J
    Pharmazie; 2002 Apr; 57(4):252-5. PubMed ID: 11998445
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Kinetics and mechanisms of etodolac degradation in aqueous solutions.
    Lee YJ; Padula J; Lee HK
    J Pharm Sci; 1988 Jan; 77(1):81-6. PubMed ID: 2964523
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stability of Octastatin, a somatostatin analog cyclic octapeptide, in aqueous solution.
    Jang SW; Woo BH; Lee JT; Moon SC; Lee KC; DeLuca PP
    Pharm Dev Technol; 1997 Nov; 2(4):409-14. PubMed ID: 9552470
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of pH, temperature and buffers on cefepime degradation kinetics and stability predictions in aqueous solutions.
    Fubara JO; Notari RE
    J Pharm Sci; 1998 Dec; 87(12):1572-6. PubMed ID: 10189269
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.